Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Foresee Pharmaceuticals Revenue

Foresee Pharmaceuticals had revenue of 80.31M TWD in the quarter ending March 31, 2026, a decrease of -27.30%. This brings the company's revenue in the last twelve months to 401.12M, down -5.68% year-over-year. In the year 2025, Foresee Pharmaceuticals had annual revenue of 431.27M with 3.01% growth.

• Revenue (ttm): 401.12M
• Revenue Growth: -5.68%
• P/S Ratio: 30.24
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 12.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	431.27M	12.59M	3.01%
Dec 31, 2024	418.69M	223.65M	114.67%
Dec 31, 2023	195.04M	-106.47M	-35.31%
Dec 31, 2022	301.51M	75.48M	33.39%
Dec 31, 2021	226.03M	-4.41M	-1.91%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error